Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
29.96
-0.51 (-1.67%)
At close: Aug 31, 2026, 4:00 PM EDT
29.96
0.00 (0.00%)
After-hours: Aug 31, 2026, 6:30 PM EDT
Oscar Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Investments | 6,081 | 2,687 | 2,440 | 1,055 | 1,620 | 1,432 |
Cash & Equivalents | 4,076 | 2,774 | 1,527 | 1,870 | 1,559 | 1,104 |
Reinsurance Recoverable | 196.54 | 99.75 | 291.54 | 241.19 | 892.89 | 431.99 |
Other Receivables | 560.81 | 498.71 | 380.67 | 253.19 | 266.34 | 182.86 |
Property, Plant & Equipment | 101.49 | 139.89 | 123.95 | 124.8 | 127.89 | 119.57 |
Other Current Assets | 60.32 | 24.33 | 21.32 | 6.56 | 6.45 | - |
Other Long-Term Assets | 151.31 | 101.13 | 56.12 | 50.27 | 54.24 | 51.68 |
Total Assets | 11,227 | 6,325 | 4,840 | 3,601 | 4,527 | 3,322 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 525.71 | 633 | 418.88 | 259.19 | 285.02 | 219.96 |
Insurance & Annuity Liabilities | - | 2,588 | 1,558 | 1,063 | 1,522 | 823.64 |
Unpaid Claims | 1,898 | 1,455 | 1,357 | 965.99 | 937.73 | 513.58 |
Unearned Premiums | 167.51 | 166.2 | 74.39 | 65.92 | 79 | 75.04 |
Reinsurance Payable | 2.56 | 3.58 | 41.35 | 61.02 | 427.65 | 205.23 |
Current Portion of Leases | - | 16.72 | 13.55 | 14.18 | 12.82 | 14.83 |
Long-Term Debt | 431.63 | 430.1 | 299.56 | 298.78 | 298 | - |
Long-Term Leases | 50.47 | 51.99 | 60.65 | 66.8 | 72.18 | 76.84 |
Other Long-Term Liabilities | - | 0 | 0.63 | 0.77 | 0.11 | - |
Total Liabilities | 9,172 | 5,345 | 3,824 | 2,795 | 3,634 | 1,929 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 4,317 | 4,257 | 3,870 | 3,682 | 3,509 | 3,394 |
Retained Earnings | -2,254 | -3,294 | -2,851 | -2,877 | -2,606 | -2,000 |
Treasury Stock | -2.92 | -2.92 | -2.92 | -2.92 | -2.92 | -2.92 |
Comprehensive Income & Other | -8.25 | 18.03 | -1.83 | 1.31 | -9.72 | -3.67 |
Total Common Equity | 2,052 | 977.65 | 1,014 | 803.97 | 890.38 | 1,387 |
Minority Interest | 3.13 | 3.09 | 2.84 | 2.15 | 2.02 | 5.29 |
Shareholders' Equity | 2,055 | 980.74 | 1,016 | 806.12 | 892.4 | 1,393 |
Total Liabilities & Equity | 11,227 | 6,325 | 4,840 | 3,601 | 4,527 | 3,322 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Filing Date Shares Outstanding | 308.33 | 297.43 | 250.25 | 229.41 | 215.99 | 210.08 |
Total Common Shares Outstanding | 308.27 | 297.37 | 250.17 | 229.07 | 215.98 | 210.01 |
Total Debt | 482.1 | 498.8 | 373.75 | 379.76 | 383 | 91.67 |
Net Cash (Debt) | 3,594 | 2,275 | 1,153 | 1,491 | 1,176 | 1,012 |
Net Cash Growth | 60.30% | 97.27% | -22.62% | 26.79% | 16.13% | 48.04% |
Net Cash Per Share | 12.27 | 8.67 | 4.34 | 6.72 | 5.53 | 5.66 |
Book Value Per Share | 6.66 | 3.29 | 4.05 | 3.51 | 4.12 | 6.61 |
Tangible Book Value | 2,052 | 977.65 | 1,014 | 803.97 | 890.38 | 1,387 |
Tangible Book Value Per Share | 6.66 | 3.29 | 4.05 | 3.51 | 4.12 | 6.61 |
Leasehold Improvements | - | 25.53 | 26.39 | 25.3 | 25.3 | 25.75 |